Source: Eur Respir J, 51 (2) 1702560; 10.1183/13993003.02560-2017
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Joan B. Soriano, Pierre-Régis Burgel. On Don Quixote and pink puffers: multi-organ loss of tissue COPD. Eur Respir J, 51 (2) 1702560; 10.1183/13993003.02560-2017

Member's Comments

No comment yet.

Related content which might interest you: The pink puffer and blue bloater revisited (Nutritional assessment and therapy in COPD: ERS statement) Source: International Congress 2016 – Nutrition and respiratory health Year: 2016 Pulmonary rehabilitation and severe exacerbations of COPD: solution or white elephant? Source: ERJ Open Res 2015; 1: 00050-2015 Year: 2015 Emphysema and extrapulmonary tissue loss in COPD: a multi-organ loss of tissue phenotype Source: Eur Respir J, 51 (2) 1702146; 10.1183/13993003.02146-2017 Year: 2018 Tortoise or hare? An alternative approach to pulmonary rehabilitation in a single patient with severe COPD Source: Eur Respir J 2003; 22: Suppl. 45, 329s Year: 2003 Classifying interstitial lung diseases in a fractal lung: a morphologist's view "anno Domini 2000" Source: Eur Respir J 2001; 18: 107S-113S Year: 2001 U-BIOPRED: Towards phenotype handprints of severe asthma Source: Annual Congress 2009 - EU Research Programmes. IMI: 1. U-BIOPRED asthma 2. PROactive COPD Year: 2009 Do respiratory patients with chronic hypoxaemia favour the colour blue? Source: Eur Respir J 2006; 28: Suppl. 50, 863s Year: 2006 The blue bloater phenotype in COPD is associated with metabolic syndrome Source: Annual Congress 2008 - Comorbidities in COPD Year: 2008 COPD; IPF; lung cancer in same individual: Can it be called 'AJMERITES SYNDROME? Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Demystifying fibrotic hypersensitivity pneumonitis diagnosis: it's all about shades of grey Source: Eur Respir J, 54 (1) 1900906; 10.1183/13993003.00906-2019 Year: 2019 Mortality in interstitial lung disease: do race and skin colour matter? Source: Eur Respir J, 51 (6) 1800892; 10.1183/13993003.00892-2018 Year: 2018 Oxygen therapy in COPD and interstitial lung disease: navigating the knowns and unknowns Source: ERJ Open Res, 5 (3) 00118-2019; 10.1183/23120541.00118-2019 Year: 2019 COPD research award ceremony - 1st prize Source: Annual Congress 2007 - Complex chronic comorbidities of COPD Year: 2007 Respiratory bronchiolitis-associated interstitial lung disease - RB-ILD Source: Respipedia Article Year: 2016 Dyspnoea in a retired coalminer: only coalworkers' pneumoconiosis? Source: Annual Congress 2005 - Clinical Grand Round: an interactive session Year: 2005 Late Breaking Abstract - Change in airway volume, measured with functional respiratory imaging (FRI), differentiates between stable and progressive idiopathic pulmonary fibrosis (IPF) Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019 Acute exacerbations of idiopathic pulmonary fibrosis: tough to define; tougher to manage Source: Eur Respir J, 49 (5) 1700811; 10.1183/13993003.00811-2017 Year: 2017 Interstitial lung disease (ILD) and multicompartment assessment of CTD: where should the respiratory physician begin? Source: Virtual Congress 2020 – Rheumatology: understanding connective tissue disease in patients with interstitial lung disease Year: 2020 Red blood cell distribution width in patients with chronic obstructive lung disease:how is changed in exacerbation? Source: International Congress 2017 – Airway disease and exacerbations Year: 2017